Oracle’s $300 Billion OpenAI Bet Hangs on a Single Question: Can the Customer Pay?

Oracle's $638B backlog hinges on OpenAI's creditworthiness, with massive capex needs and a BBB- rating fueling investor concerns.

Oracle shares closed the week at €101.20, shedding 4.08 percent on Friday alone, and touched a fresh 52-week low of €101.06 the following session. The stock now trades nearly 64 percent below its September 2025 record of €280.70, with a 14-day relative strength index of 27.6 — deep in oversold territory. The technical picture screams "bounce," but the fundamental one whispers something far more unsettling.

The company’s trajectory no longer hinges on cloud growth or revenue momentum. It rests on the creditworthiness of a single, unlisted customer: OpenAI.

A Backlog That Dwarfs the Company Itself

Oracle’s remaining performance obligations — the backlog of contracts yet to be recognized as revenue — hit a staggering $638 billion in the fiscal year ended May 31, 2026. That figure exceeds Oracle’s own market capitalization and represents a 363 percent surge from the prior year. More than half of that total, roughly $300 billion, comes from a single five-year agreement with OpenAI, set to begin in 2027.

The problem isn’t demand. It’s that converting those commitments into cash requires capital on a scale Oracle has never managed before. Capital expenditures reached $55.7 billion in fiscal 2026, blowing a $23.7 billion hole in free cash flow — up from a mere $394 million deficit the year before. For fiscal 2027, management plans to spend as much as $95 billion on infrastructure, funded by a $40 billion capital raise split between debt and equity.

S&P responded by downgrading Oracle’s credit rating to BBB-, just one notch above junk, and explicitly flagged OpenAI’s credit risk in the company’s public rating assessment.

The Cash Gap That Wall Street Can’t Ignore

Unlike Microsoft, Alphabet, and Amazon — which can largely fund their AI buildouts from operating cash flow — Oracle lacks that cushion. The company must burn cash and tap capital markets at a moment when its legacy software business faces pressure from the very AI tools it’s trying to sell.

The math is unforgiving. In fiscal 2026, Oracle raised $43 billion in debt and $5 billion in equity. For the current year, it plans another $40 billion, including a $20 billion at-the-market equity offering. Each new dollar of borrowing carries a double risk: dilution for existing shareholders or higher interest costs if bond markets demand a bigger risk premium.

Yet Oracle continues to pay a dividend — $0.50 per share as of July 10 — even as it leans ever harder on credit markets. That balancing act may define the stock’s next chapter as much as any quarterly earnings number.

A $638 Billion Accounting Construct

The RPO figure, for all its headline-grabbing size, remains an accounting construct — a future commitment, often conditional and always renegotiable. Multi-year software contracts can be trimmed or canceled at renewal. A technology shift or economic disruption could quickly undermine Oracle’s ability to turn that backlog into recognized revenue.

Analysts expect only about 12 percent of the RPO to convert into revenue in the coming year, giving Oracle a long time horizon — provided its customers stay solvent. The average analyst price target stands at €219.14, implying 116.5 percent upside from current levels. But that target predates the latest sell-off and has yet to be tested against potential further downgrades.

The bull case rests on the fourth quarter ended May 31, 2026, when revenue rose 21 percent to $19.2 billion and Oracle Cloud Infrastructure surged 93 percent to $5.8 billion. Only a fraction of the backlog needs to materialize to justify current spending levels. And notably, Oracle’s RPO now exceeds that of Microsoft, a far larger company.

The Bear Case: Concentration Risk and a Delayed IPO

The bear case is equally stark. Oracle has effectively bet its balance sheet on a handful of AI customers whose own financial stability remains unproven. OpenAI’s planned IPO has been pushed to 2027, prolonging the period during which Oracle carries concentrated counterparty risk without the transparency of public markets.

A recent warning signal: Oracle lost a data center deal to Microsoft, demonstrating that competitive dynamics among cloud providers can shift quickly. With net debt already elevated and free cash flow deeply negative, any additional capital raise for 2027 carries the risk of shareholder dilution or higher interest costs — or both.

Morgan Stanley strategists estimate global AI-related debt issuance will nearly double in 2026 to roughly $570 billion, with hyperscaler investment topping $1 trillion by 2027. Oracle is simply the company most exposed to this trend without the balance sheet buffer of its larger rivals — making the stock a proxy for how the market is pricing the entire AI infrastructure buildout.

The Next Test Arrives in September

The oversold technical condition could produce a short-term stabilization. But a sustainable recovery depends on whether Oracle can demonstrate that its largest customers — above all, OpenAI — can meet their multi-year payment obligations without renegotiation.

If the backlog holds and cloud growth continues at its current pace, the path back toward analyst consensus remains realistic. If credit pressure intensifies or a major customer shows signs of payment strain, the debt burden will likely weigh on the stock regardless of headline revenue growth.

Oracle’s first-quarter fiscal 2027 report, due in September, will provide the first concrete evidence of whether the planned capital raise and backlog conversion are unfolding as management has promised. Until then, the stock remains caught between a record order book and the gnawing question of who ultimately pays for it.